Ipamorelin, unlike other GHS-R agonists, selectively stimulates only GH release, with no effect on other pituitary hormones such as ACTH or prolactin
Product quality is a major confounder: research-grade material sold "for research use only" is not manufactured to pharmaceutical standards, and contaminants, incorrect concentrations, or endotoxins can cause harms that have nothing to do with the peptide itself
Anemia, sleep loss, thyroid disease, infection, depression, heart disease, and other causes may need evaluation
Yes when medically supervised and compounded through reputable pharmacies
The FDA prioritises safety and efficacy and has not approved any injectable product for skin whitening
Methods: TAA was interperitoneally injected to mouse for 12 weeks to induce liver injury and fibrosis, and efocipegtrutide was administered during last 10 weeks